A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Modern views on amlodipine and new S-amlodipine medications
2011
CARDIOVASCULAR THERAPY AND PREVENTION
The review presents the latest evidence on the calcium antagonist amlodipine, summarizing its mechanisms of action, its pleiotropic, endothelial function-related effects, and its anti-atherogenic activity. Amlodipine suppresses the proliferation of vascular smooth myocytes and extracellular matrix and improves endothelial vasodilatation, despite the absence of L-type calcium channels in these cells. This mechanism is related to an increase in endothelial nitric oxide (NO) release. The results
doi:10.15829/1728-8800-2011-4-117-120
fatcat:emjrr7zf5zhfvkjfnorfv6wb3e